Researchers say people using a common allergy nasal spray, azelastine, were 69% less likely to contract COVID-19.
Incorporating the art of conscious breathing into a daily routine can help with emotional regulation, boost mood, and ...
Nerandomilast is the first FDA-approved treatment for IPF in over a decade, targeting lung function decline. The FDA has ...
Researchers evaluated whether interferon-α nasal spray reduces the incidence of COVID-19 or other respiratory viral infections among adults with cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback